SR ONE CAPITAL MANAGEMENT, LLC, Ten Percent Owner at Arcellx Inc, holds 6.21M shares in eFFECTOR Therapeutics (Ticker: EFTR), holds 4.49M shares in Arcellx Inc (Ticker: ACLX). Most recently, SR ONE CAPITAL MANAGEMENT, LLC Sold ― shares of eFFECTOR Therapeutics on Nov 29, 2023 for an estimated value of 365.50K.